secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-09-16T23:59:59+00:00
Accession:  0001607062-21-000331
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma settles ChemDiv lawsuit for $800k, contingent on SEC filing by Sept 24
--------------------------------------------------------------------------------

- Regen to pay $800k lump sum by Sept 30, 2021, to settle ChemDiv's breach-of-contract lawsuit over ~$1.2M unpaid invoices.
- Settlement contingent on Regen filing acceptable SEC documents by Sept 24 to maintain listing status.
- Upon payment, ChemDiv dismisses litigation with prejudice and transfers NR2F6 research data, compounds, and IP to Regen and Zander.
- If payment not made by Sept 30, agreement void and litigation continues with trial set for Oct 29, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000331/0001607062-21-000331-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000331/rgbp091521form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000331

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer